Back to search

Article

Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes during development

2021-12-17

Abstract excerpt

<h4>ABSTRACT</h4> Rett Syndrome (RTT) is a rare X-linked neurodevelopmental disorder, mainly caused by mutations in the MECP2 gene. Reduction in monoamine levels in RTT patients and mouse models suggested the possibility to rescue clinical phenotypes through antidepressants. Accordingly, we tested mirtazapine (MTZ), a noradrenergic and specific-serotonergic tetracyclic antidepressant (NaSSA). In previous studies...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1ce88474-1cf3-5902-8525-1cc4da1b719e
DOI
10.1101/2021.12.17.473107
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes during developmentDOI 10.1101/2021.12.17.473107
Select a neighboring publication to make it the new centre.